Lung function testing is the gold standard for COPD diagnosis but clinical guidelines [15] advise against screening asymptomatic patients for COPD with due to the associated costs [16]. Thus, asymptomatic smokers may easily be missed; a single question, such as TTFC, which could be used as a screening tool for COPD risk in smokers would be cost-effective in terms of time and economic and healthcare resources.
